degenerative disc disease


Also found in: Acronyms, Wikipedia.

de·gen·e·ra·tive disc dis·ease

(dĕ-jen'ĕr-ă-tiv disk di-zēz')
Protrusion, herniation, or fragmentation of an intervertebral disc beyond its borders with potential compression of a nerve root, the cauda equina in the lumbar region, or the spinal cord at higher levels.
References in periodicals archive ?
This minimally invasive stem cell procedure, if successful, may offer improvement to patients with chronic pain from degenerative disc disease.
Drugs profile discussed in this report include: AdipoCell, ALLOB, brtxDISC, CHND-1, dibotermin alfa, MPC-25Osteo, NuQu Cell-Based Therapy, Peptides to Antagonize IL-1 Receptor for Dermatology, Musculoskeletal and CNS Disorders, Poly N-Acetyl Glucosamine Hydrogel, Recombinant Protein for Degenerative Disc Disease, S-414114, Stem Cell Therapy, Stem Cell Therapy for Degenerative Disc Disease, Stem Cell Therapy for Degenerative Disc Disease, Stem Cell Therapy for Degenerative Disc Disease, TG-D, YH-14618.
Degenerative disc disease occurs when discs in the spine are deteriorating or damaged, and can be extremely painful and debilitating in patients who generally lead active lives.
In fact, in a study of the results of lumbar anterior interbody fusion for patients with degenerative disc disease, Flynn and Joque (1979) found that only one fourth of the compensation-related cases were able to return to work as compared to private insurance cases.
Degenerative Disc Disease - Pipeline Review, Half Year is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team.
Anchor FS is indicated for posterior surgical treatment of any or all of the following in the lumbar region of the spine, at single or multiple levels: trauma, including spinal fractures and/or dislocations; spondylolisthesis; spondylolysis; pseudoarthrosis or failed previous fusions that are symptomatic or may cause secondary instability or deformity; degenerative disc disease as defined by back pain of discogenic origin as confirmed by patient history with degeneration of the disc as confirmed by radiographic studies; and/or degenerative disease of the facets with instability.
The medical device company designs, develops, and sells products that treat degenerative disc disease of the spine's lower lumbar region.
clinical study to evaluate the potential benefits of its Wallis(R) Mechanical Normalization System, a new spinal implant technology for the treatment of mild to moderate degenerative disc disease designed to stabilize the spine and reduce pain while preserving range of motion.
An expert advisory panel to the US Food and Drug Administration (FDA) has unanimously backed approval of a genetically engineered bone graft that would offer patients with degenerative disc disease an alternative to having their own bone harvested.
SpinalMotion, developer of the investigational Kineflex[R] lumbar and Kineflex[R] |C cervical disc implants for treating degenerative disc disease (DDD), today announced that it has received CE Mark for two sub-5mm Kineflex|C cervical total disc replacements to address the widest range of patients by best matching disc height to the existing anatomy.
Food and Drug Administration (FDA) for spinal fusion treatment of symptomatic degenerative disc disease (DDD).
Spinal Kinetics has completed its 10,000th implant of the M6 Artificial Spinal Disc, which treats patients suffering from degenerative disc disease.

Full browser ?